awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38827897-432B08E3-8016-452B-8946-99B7670B091A
Q38827897-432B08E3-8016-452B-8946-99B7670B091A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38827897-432B08E3-8016-452B-8946-99B7670B091A
Challenging chemoresistant metastatic colorectal cancer: therapeutic strategies from the clinic and from the laboratory.
P2860
Q38827897-432B08E3-8016-452B-8946-99B7670B091A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38827897-432B08E3-8016-452B-8946-99B7670B091A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2c343d12614b8f4a3dd16c3570752c03a45f2c66
P2860
HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab.